Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.44 is 33% above its 5-year average of -2.16, near the high end of its 5-year range (-4.60–-1.41).
52.08% above its 12-month average of -3.00.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.03.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 14 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.44
EARNINGS PER SHARE (EPS) AVG TTM
-3.00
EARNINGS PER SHARE (EPS) AVG 3Y
-2.43
EARNINGS PER SHARE (EPS) AVG 5Y
-2.16
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+52.08%
CURRENT VS 3Y AVG
+40.68%
CURRENT VS 5Y AVG
+33.28%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Tempus AI, Inc.
Market Cap
$10.41B
Earnings Per Share (EPS)
-1.44
TTM Avg
-3.00
3Y Avg
-2.43
5Y Avg
-2.16
Market Cap
$10.39B
Earnings Per Share (EPS)
0.19
TTM Avg
14.72
3Y Avg
15.46
5Y Avg
14.11
Market Cap
$10.45B
Earnings Per Share (EPS)
24.38
TTM Avg
20.29
3Y Avg
15.04
5Y Avg
13.87
Market Cap
$10.66B
Earnings Per Share (EPS)
N/A
TTM Avg
1.92
3Y Avg
1.82
5Y Avg
4.51
Market Cap
$10.74B
Earnings Per Share (EPS)
5.76
TTM Avg
5.64
3Y Avg
5.43
5Y Avg
9.01
Market Cap
$10.05B
Earnings Per Share (EPS)
8.25
TTM Avg
-18.74
3Y Avg
-45.28
5Y Avg
14.90
Market Cap
$10.02B
Earnings Per Share (EPS)
6.38
TTM Avg
5.63
3Y Avg
4.78
5Y Avg
4.31
Market Cap
$10.02B
Earnings Per Share (EPS)
3.89
TTM Avg
2.37
3Y Avg
1.93
5Y Avg
1.71
Market Cap
$10.01B
Earnings Per Share (EPS)
3.43
TTM Avg
3.18
3Y Avg
3.37
5Y Avg
3.47
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tempus AI, Inc. (TEM) | $10.41B | -1.44 | -3.00 | -2.43 | -2.16 |
| Molina Healthcare, Inc. (MOH)vs › | $10.39B | 0.19 | 14.72 | 15.46 | 14.11 |
| Universal Health Services, Inc. (UHS)vs › | $10.45B | 24.38 | 20.29 | 15.04 | 13.87 |
| The Cooper Companies, Inc. (COO)vs › | $10.66B | N/A | 1.92 | 1.82 | 4.51 |
| Align Technology, Inc. (ALGN)vs › | $10.74B | 5.76 | 5.64 | 5.43 | 9.01 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.05B | 8.25 | -18.74 | -45.28 | 14.90 |
| The Ensign Group, Inc. (ENSG)vs › | $10.02B | 6.38 | 5.63 | 4.78 | 4.31 |
| Globus Medical, Inc. (GMED)vs › | $10.02B | 3.89 | 2.37 | 1.93 | 1.71 |
| Henry Schein, Inc. (HSIC)vs › | $10.01B | 3.43 | 3.18 | 3.37 | 3.47 |
| Bio-Techne Corporation (TECH)vs › | $11.31B | 1.16 | 0.82 | 1.13 | 1.19 |
Trailing EPS (TTM)
$-1.44
Forward EPS (Est.)
$-0.20
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.41 |
| 2024-12-31 | -4.60 |
| 2023-12-31 | -1.73 |
| 2022-12-31 | -1.97 |
| 2021-12-31 | -1.75 |
| 2020-12-31 | -1.49 |
| 2019-12-31 | -0.92 |
